Harrow Health is trading 5.3% up today at $47.26 as investors step back in to partially reverse a sharp earnings-related plunge from the prior session.
- The stock previously dropped to $40.00 in after-hours trading following a widely covered Q1 2026 earnings miss.
- Buyers are returning despite heavy skepticism regarding the company's second-half guidance and broader market weakness.